Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: The present invention relates to provision of a novel compound that has an activity of promoting insulin secretion from pancreatic ? cells and thus is useful as a prophylaxis and/or therapeutic agent for diseases caused by hyperglycemia such as diabetes mellitus, and the compound represented by the following formula (1): wherein one of A and B represents a nitrogen atom and the other represents a nitrogen atom or CR10, X represents an oxygen atom, a sulfur atom or —(CH2)n-N(R12)—, Y represents an oxygen atom, a sulfur atom or —N(R13)—, and R1 to R9 each represent a hydrogen atom or another substituent, or a salt thereof, or a solvate of the compound or the salt.

Abstract: Disclosed is a compound which has both an angiotensin-II receptor antagonistic activity and a PPAR? activation activity and is useful as a prophylactic and/or therapeutic agent for hypertension, heart diseases, angina pectoris, cerebrovascular disorders, cerebral circulatory disorders, ischemic peripheral circulatory disorders, renal diseases, arteriosclerosis, inflammatory diseases, type-2 diabetes, diabetic complications, insulin resistance syndrome, syndrome X, metabolic syndrome and hyperinsulinemia. [In the formula, A represents a 5- to 10-membered heteroaryl group; R1 and R2 independently represent a C1-6 alkyl group; and each of R3 to R5 is absent or represents H, a halogen atom, OH, NO2, a halo-C1-6 alkyl group, a (substituted) C1-6 alkoxy group, a (substituted) C3-6 cycloalkyloxy group, or a 5- to 10-membered heteroaryl group.

Abstract: The present invention relates to provision of a novel compound that has an activity of promoting insulin secretion from pancreatic ? cells and thus is useful as a prophylaxis and/or therapeutic agent for diseases caused by hyperglycemia such as diabetes mellitus, and the compound represented by the following formula (1): wherein one of A and B represents a nitrogen atom and the other represents a nitrogen atom or CR10, X represents an oxygen atom, a sulfur atom or —(CH2)n-N(R12)—, Y represents an oxygen atom, a sulfur atom or —N(R13)—, and R1 to R9 each represent a hydrogen atom or another substituent, or a salt thereof, or a solvate of the compound or the salt.

Abstract: Disclosed is novel compound and medicinal formulation containing same, possessing both angiotensin II receptor blocking and PPAR? activation effect, of use as a medicine for prevention and/or treatment of hypertension, heart disease, angina pectoris, cerebrovascular disorder, cerebral circulatory disturbances, post-ischemic peripheral circulatory damage, renal disease, arteriosclerosis, inflammatory disorder, type 2 diabetes, diabetic complications, insulin resistance syndrome, syndrome X, metabolic syndrome and hyperinsulinaemia. Further disclosed is the general formula I (where one or both of R1 and R2 represent a C1-6 alkyl group, R3 represents a C1-6 alkyl group which may contain one or more substituent groups selected from group A, or a C3-8 cycloalkyl group which may contain one or more substituent groups selected from group B.) which represents the compound, and salts thereof, solvates thereof, and medicinal compositions containing any of these.

Abstract: According to one embodiment, a control module determines whether a second authentication key is present in a authentication key storage device when an information processing apparatus is powered on. The control module displays an identification code input screen for inputting an identification code if the second authentication key is not present, causes a storage device to execute an identification code authentication process of determining whether the identification code which is input to the identification code input screen agrees with the first identification code, and generates a third authentication key and stores the third authentication key in the authentication key storage device if the identification code authentication process is successfully carried out.

Abstract: Disclosed is a novel 1-(biphenyl-4-yl-methyl)-1H-imidazole derivative represented by general formula (I), which has both angiotensin II receptor antagonist activity and PPAR-? activating activity and is useful as a prophylactic and/or therapeutic agent for cardiovascular diseases and metabolic diseases. Also disclosed is a pharmaceutical composition which contains the novel 1-(biphenyl-4-yl-methyl)-1H-imidazole derivative. In general formula (I), ring A represents a group represented by formula (II) or (III); R1 represents a C1-6 alkyl group; R2 represents a C1-6 alkyl group which may be substituted by a hydroxy group, or a group represented by formula —CO—R4 (wherein R4 represents a hydroxy group, a C1-6 alkoxy group, an amino group, a mono(C1-6 alkyl)amino group, a di(C1-6 alkyl)amino group, a morpholino group, a piperidino group or a pyrrolidino group); R3 represents a halogen atom or a C1-6 alkoxy group; and X and Y may be the same or different and each represents a nitrogen atom or CH.

Abstract: An ?-phenoxybenzeneacetic acid derivative represented by general formula (I), which has both an angiotensin II receptor antagonistic activity and a PPAR? activation activity and is useful as a prophylactic and/or therapeutic agent for hypertension, metabolic syndrome or the like, a salt of the derivative, or a solvate of the derivative or the salt; and a pharmaceutical composition containing the derivative, the salt or the solvate.

Abstract: Disclosed is a compound which has both an angiotensin-II receptor antagonistic activity and a PPAR? activation activity and is useful as a prophylactic and/or therapeutic agent for hypertension, heart diseases, angina pectoris, cerebrovascular disorders, cerebral circulatory disorders, ischemic peripheral circulatory disorders, renal diseases, arteriosclerosis, inflammatory diseases, type-2 diabetes, diabetic complications, insulin resistance syndrome, syndrome X, metabolic syndrome and hyperinsulinemia. [In the formula, A represents a 5- to 10-membered heteroaryl group; R1 and R2 independently represent a C1-6 alkyl group; and each of R3 to R5 is absent or represents H, a halogen atom, OH, NO2, a halo-C1-6 alkyl group, a (substituted) C1-6 alkoxy group, a (substituted) C3-6 cycloalkyloxy group, or a 5- to 10-membered heteroaryl group.

Abstract: Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin.

Abstract: Provided are novel compounds that have both angiotensin II receptor-antagonist effects and PPAR-activating effects that are useful as agents for preventing and/or treating hypertension, heart disease, angina, cerebral vascular accident, cerebrovascular disorder, ischemic peripheral circulatory disorder, kidney disease, atherosclerosis, inflammatory disease, type 2 diabetes mellitus, diabetic complication, insulin resistance syndrome, Syndrome X, metabolic syndrome, and hyperinsulinemia.

Abstract: According to one embodiment, an electronic apparatus includes a display, an operating module, a power saving module, a sensor and a controller. The power saving module is configured to turn off a screen of the display when a non-operating period of the operating module reaches a reference period. The sensor is configured to detect a vibration. The controller is configured to change the reference period from a first value given as the initial value to a second value longer than the first value when the sensor detects a vibration.

Abstract: According to one embodiment, an information processing apparatus includes a processor including a register file which holds physical registers to which general purpose registers provided by an instruction set architecture are assigned, a virtual register assigning unit which assigns a virtual address in the main memory space to a physical register in the register file based on a request from a program, and records a correspondence between each of the virtual addresses and a corresponding one of the physical registers in a virtual register conversion table, and an access converting unit which determines whether or not a virtual address to be accessed is recorded in the virtual register conversion table managed by the virtual register assigning unit, and executes, when the virtual address is recorded therein, processing of accessing the physical register of which a correspondence to the virtual address is recorded in the virtual register conversion table.

Abstract: According to one embodiment, an information processing apparatus includes a processor including a register file which holds physical registers to which general purpose registers provided by an instruction set architecture are assigned, a virtual register assigning unit which assigns a virtual address in the main memory space to a physical register in the register file based on a request from a program, and records a correspondence between each of the virtual addresses and a corresponding one of the physical registers in a virtual register conversion table, and an access converting unit which determines whether or not a virtual address to be accessed is recorded in the virtual register conversion table managed by the virtual register assigning unit, and executes, when the virtual address is recorded therein, processing of accessing the physical register of which a correspondence to the virtual address is recorded in the virtual register conversion table.

Abstract: According to one embodiment, an information processing apparatus includes a first processor which has a first instruction set, a second processor which has a second instruction set, a storage unit which stores a program including a first program module which is described by using the second instruction set and causes the second processor to execute a first process including the arithmetic process, and a second program module which is described by using the first instruction set and causes the first processor to execute a process which is the same as the first process, and a control unit which switches a mode for executing the program between a first mode in which the first program module is assigned to the second processor and a second mode in which the second program module is assigned to the first processor.

Abstract: According to one embodiment, an information processing apparatus comprises a plurality of temperature transmission sections provided in each of first and second semiconductor circuits, and configure to transmit first measured temperature of one of the first and second semiconductor circuits to the other of first and second semiconductor circuits when the first measured temperature is higher than a threshold temperature, and a plurality of operation speed varying sections provided in each of the first and second semiconductor circuits configure to reduce operation speed of the processor circuit possessed by the other of first and second semiconductor circuits, when the received first measured temperature is higher than the second measured temperature of the other of the first and second semiconductor circuits.

Abstract: There is provided a network controller setting method applied to an information processing apparatus with a plurality of network controllers. The method includes displaying a screen used to specify use/nonuse of each of the plurality of network controllers, and setting at least one of the plurality of network controllers, to which the use is not specified on the screen, in a disabled state. With this method, the unused network controllers can be brought reliably into the disabled state without letting the use have a sense of troublesomeness or imposing any burden on the user in setting a plurality of network controllers.

Abstract: There is provided a network controller setting method applied to an information processing apparatus with a plurality of network controllers. The method includes displaying a screen used to specify use/nonuse of each of the plurality of network controllers, and setting at least one of the plurality of network controllers, to which the use is not specified on the screen, in a disabled state. With this method, the unused network controllers can be brought reliably into the disabled state without letting the use have a sense of troublesomeness or imposing any burden on the user in setting a plurality of network controllers.